Patents by Inventor Jianhong ZHAO

Jianhong ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WEARABLE DRUG DELIVERY DEVICE WITH INCORPORATED FILTRATION
    Publication number: 20230414865
    Abstract: A drug delivery device including a reservoir operable to contain a liquid drug, a fluid outlet including an outlet reservoir opening and an outlet fluid channel, wherein the outlet reservoir opening has a volume and is fluidly coupled to the outlet fluid channel, and an outlet filter plug operable to fill the volume of the outlet reservoir opening and collect particulate material as the liquid drug is expelled from the reservoir.
    Type: Application
    Filed: June 23, 2023
    Publication date: December 28, 2023
    Inventors: Jianhong ZHAO, Soroush KAMRAVA, James CAUSEY, Daniel BARRETT, Craig BRODEUR, Eric DUHAMEL, Ann LIU, Ian MCLAUGHLIN
  • INSTRUMENT FOR A MEDICAMENT DELIVERY DEVICE THAT ACTS AS NEEDLE AND CANNULA
    Publication number: 20230364329
    Abstract: Exemplary embodiments may provide a medicament delivery device that includes a single instrument for piercing the skin of the user and for acting as a conduit for delivering medicament to the user subcutaneously. The exemplary embodiments may reduce discomfort caused by a rigid cannula or needle. The exemplary embodiments may provide instruments that are configured to be comfortable to the user when the instruments are in place beneath the skin of the user, such as when a medicament delivery device is delivering medicament to the user.
    Type: Application
    Filed: May 8, 2023
    Publication date: November 16, 2023
    Inventors: Jianhong ZHAO, David NAZZARO, Lucas MCGAHREN, Eric DUHAMEL
  • Substituted benzoylamino-indan-2-carboxylic acids and related compounds
    Patent number: 8569535
    Abstract: The present invention relates to novel compounds of the formula Ia: in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity, and are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: October 29, 2013
    Assignee: Sanofi
    Inventors: Thomas Joseph Caulfield, Jennifer Williford Clemens, Robert S. Francis, Brian Scott Freed, Stanly John, Tieu-Binh Le, Brian Pedgrift, Antonio Daniel Ramos, Gerard Charles Rosse, Martin Smrcina, David Squire Thorpe, William Shelly Wire, Jianhong Zhao
  • METHOD AND APPARATUS FOR MAKING A POROUS BIODEGRADEABLE MEDICAL IMPLANT DEVICE
    Publication number: 20120046622
    Abstract: A method of producing a porous biodegradable medical implant device, the method comprising providing a mixed blend comprising a mixture of at least two biocompatible materials having different degradation or solubility characteristics; molding the mixed blend to produce a molded part; and processing the molded part to remove one of the at least two biocompatible materials by a predetermined amount from the molded part to produce the porous biodegradable medical implant device.
    Type: Application
    Filed: July 20, 2011
    Publication date: February 23, 2012
    Inventors: Jianhong ZHAO, Xu Li, Ge Chen, Jia En Low, Kui Liu
  • SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS
    Publication number: 20100113462
    Abstract: The present invention relates to novel compounds of the formula I: wherein in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
    Type: Application
    Filed: November 30, 2009
    Publication date: May 6, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Thomas J. CAULFIELD, Jennifer Williford CLEMENS, Robert S. FRANCIS, Brian S. FREED, Stanly JOHN, Tieu-Binh LE, Brian PEDGRIFT, Antonio D. RAMOS, Gerard Charles ROSSE, Martin SMRCINA, David S. THORPE, William WIRE, Jianhong ZHAO